Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,545 | 7,020 | 6,883 | 2,357 | 4,651 |
| Gross Profit | 1,545 | 7,020 | 6,883 | 2,357 | 4,651 |
| Operating Expenses | 288,912 | 202,098 | 161,425 | 117,591 | 75,894 |
| Operating Income | -287,367 | -195,078 | -154,542 | -115,234 | -71,243 |
| Other Income | 28,610 | 37,215 | 13,113 | 2,909 | 505 |
| Pre-tax Income | -258,757 | -157,863 | -141,429 | -112,325 | -70,738 |
| Income Tax | N/A | N/A | N/A | N/A | -227 |
| Net Income Continuous | -258,757 | -157,863 | -141,429 | -112,325 | -70,511 |
| Net Income | $-258,757 | $-157,863 | $-141,429 | $-112,325 | $-70,511 |
| EPS Basic Total Ops | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
| EPS Basic Continuous Ops | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
| EPS Diluted Total Ops | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
| EPS Diluted Continuous Ops | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.45 | -2.66 | -2.23 | -1.58 |
| EBITDA(a) | $-289,842 | $-207,650 | $-157,756 | $-111,494 | $-67,884 |